Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)
CAPS Rating:
A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.
A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.
Recs
clinicals trials look good.